[HTML][HTML] Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative …
Oxidative stress (OS) is a result of the imbalance between reactive oxygen species (ROS)
and antioxidants in the body that can cause tissue damage. Oxidative stress has a …
and antioxidants in the body that can cause tissue damage. Oxidative stress has a …
[HTML][HTML] Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome
HC Arora, C Eng, DA Shoskes - Annals of translational medicine, 2017 - ncbi.nlm.nih.gov
Abstract Analysis of the human microbiome continues to reveal new and previously
unrealized associations between microbial dysbiosis and disease. Novel approaches to …
unrealized associations between microbial dysbiosis and disease. Novel approaches to …
Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
J Rees, M Abrahams, A Doble, A Cooper… - BJU …, 2015 - Wiley Online Library
Objectives To improve awareness and recognition of chronic bacterial prostatitis (CBP) and
chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and …
chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non‐specialists and …
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT
DA Shoskes, JC Nickel, MW Kattan - Urology, 2010 - Elsevier
OBJECTIVES: Large, controlled trials in chronic pelvic pain syndrome (CPPS) have failed
due to patient heterogeneity. To phenotype CPPS patients, we developed the UPOINT …
due to patient heterogeneity. To phenotype CPPS patients, we developed the UPOINT …
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial
JC Nickel, J Downey, J Clark, RW Casey… - Urology, 2003 - Elsevier
OBJECTIVES: To perform a Canadian multicenter randomized placebo-controlled trial to
evaluate the safety and efficacy of 6 weeks of levofloxacin therapy compared with placebo in …
evaluate the safety and efficacy of 6 weeks of levofloxacin therapy compared with placebo in …
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes
DA Shoskes, JC Nickel, RR Rackley… - Prostate cancer and …, 2009 - nature.com
The urologic chronic pain conditions such as chronic prostatitis/chronic pelvic pain
syndrome and interstitial cystitis are syndromes whose evaluation and management are …
syndrome and interstitial cystitis are syndromes whose evaluation and management are …
Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators
M Mamani-Matsuda, T Kauss, A Al-Kharrat… - Biochemical …, 2006 - Elsevier
Pentahydroxyflavone dihydrate, quercetin (QU) is one of common flavonols biosynthesized
by plants and has been suggested to modulate inflammatory responses in various models …
by plants and has been suggested to modulate inflammatory responses in various models …
Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity
DA Shoskes, JC Nickel, R Dolinga, D Prots - Urology, 2009 - Elsevier
OBJECTIVES: To propose a clinical phenotype system (urinary, psychosocial, organ
specific, infection, neurologic/systemic, and tenderness [UPOINT]) to classify patients with …
specific, infection, neurologic/systemic, and tenderness [UPOINT]) to classify patients with …
[HTML][HTML] Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients
V Magri, E Marras, A Restelli… - Experimental and …, 2015 - spandidos-publications.com
The complex network of etiological factors, signals and tissue responses involved in chronic
prostatitis/chronic pelvic pain syndrome (CP/CPPS) cannot be successfully targeted by a …
prostatitis/chronic pelvic pain syndrome (CP/CPPS) cannot be successfully targeted by a …
A prospective, randomized, placebo controlled, double-blind study of pelvic electromagnetic therapy for the treatment of chronic pelvic pain syndrome with 1 year of …
E Rowe, C Smith, L Laverick, J Elkabir… - The Journal of …, 2005 - Elsevier
PURPOSE:: Male chronic pelvic pain syndrome is a condition of uncertain etiology and
treatment is often unsatisfactory. There is evidence that the symptom complex may result …
treatment is often unsatisfactory. There is evidence that the symptom complex may result …